{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T18:26:22Z","timestamp":1793989582477,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010447","name":"DZHK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021703","name":"CPI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiovascular Magnetic Resonance"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.jocmr.2024.101121","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T15:51:18Z","timestamp":1730303478000},"page":"101121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance Endpoints"],"prefix":"10.1016","volume":"27","author":[{"given":"Valentina O.","family":"Puntmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"Beitzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kammerlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Voges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik D.","family":"Gabbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Doerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishwas","family":"Chamling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biykem","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Kaski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Spatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"DeLeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Windemuth-Kieselbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Harz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Santiuste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Schoeckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocmr.2024.101121_bib1","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.jacc.2022.02.003","article-title":"2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play","volume":"79","author":"Committee","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jocmr.2024.101121_bib2","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/s41591-022-02051-3","article-title":"Acute and postacute sequelae associated with SARS-CoV-2 reinfection","volume":"28","author":"Bowe","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jocmr.2024.101121_bib3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/thoraxjnl-2020-215818","article-title":"\u201cLong-COVID\u201d: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19","volume":"76","author":"Mandal","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.jocmr.2024.101121_bib4","doi-asserted-by":"crossref","unstructured":"Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Hanitsch LG, Zoller T, Steinbeis F, Haffke M, Rudolf G, Heidecker B, Bobbert T, Spranger J, Volk HD, Skurk C, Konietschke F, Paul F, Behrends U, Bellmann-Strobl J, Scheibenbogen C. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. 2022 Aug 30;13(1):5104. doi: 10.1038\/s41467-022-32507-6. Erratum in: Nat Commun. 2022 Oct 12;13(1):6009. doi: 10.1038\/s41467-022-33784-x. PMID: 36042189; PMCID: PMC9426365.","DOI":"10.1038\/s41467-022-32507-6"},{"key":"10.1016\/j.jocmr.2024.101121_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41115-3","article-title":"SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication","volume":"13","author":"Montezano","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jocmr.2024.101121_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn3777","article-title":"Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity","volume":"8","author":"Briquez","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.jocmr.2024.101121_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1164\/rccm.202108-1903LE","article-title":"Decreased fatty acid oxidation and altered lactate production during exercise in patients with post-acute COVID-19 syndrome","volume":"205","author":"Boer","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jocmr.2024.101121_bib8","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2023.02","article-title":"Cardiac involvement due to COVID-19: insights from imaging and histopathology","volume":"18","author":"Puntmann","year":"2023","journal-title":"Eur Cardiol Rev"},{"key":"10.1016\/j.jocmr.2024.101121_bib9","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1038\/s41591-022-02000-0","article-title":"Long-term cardiac pathology in individuals with mild initial COVID-19 illness","volume":"28","author":"Puntmann","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jocmr.2024.101121_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.36057","article-title":"Use of cardiopulmonary exercise testing to evaluate long COVID-19 symptoms in adults: a systematic review and meta-analysis","volume":"5","author":"Durstenfeld","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jocmr.2024.101121_bib11","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/infdis\/jiad131","article-title":"Reduced exercise capacity, chronotropic incompetence, and early systemic inflammation in cardiopulmonary phenotype long coronavirus disease 2019","volume":"228","author":"Durstenfeld","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jocmr.2024.101121_bib12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","author":"Xie","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jocmr.2024.101121_bib13","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3109\/09638288.2011.635746","article-title":"Pacing as a strategy to improve energy management in myalgic encephalomyelitis\/chronic fatigue syndrome: a consensus document","volume":"34","author":"Goudsmit","year":"2012","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.jocmr.2024.101121_bib14","first-page":"693","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","author":"Group","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocmr.2024.101121_bib15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJMoa2101643","article-title":"Tofacitinib in patients hospitalized with covid-19 pneumonia","volume":"385","author":"Guimar\u00e3es","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocmr.2024.101121_bib16","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(21)01744-X","article-title":"Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial","volume":"398","author":"Yu","year":"2021","journal-title":"Lancet (Lond, Engl)"},{"key":"10.1016\/j.jocmr.2024.101121_bib17","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/01.CIR.98.17.1742","article-title":"Improved exercise tolerance after losartan and enalapril in heart failure","volume":"98","author":"Vescovo","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jocmr.2024.101121_bib18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.amjcard.2006.01.106","article-title":"Effect of losartan and hydrochlorothiazide on exercise tolerance in exertional hypertension and left ventricular diastolic dysfunction","volume":"98","author":"Little","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jocmr.2024.101121_bib19","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0735-1097(99)00048-0","article-title":"Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise","volume":"33","author":"Warner","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jocmr.2024.101121_bib20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/eurheartj\/eht513","article-title":"Coronary microvascular dysfunction: an update","volume":"35","author":"Crea","year":"2014","journal-title":"Eur Hear J"},{"key":"10.1016\/j.jocmr.2024.101121_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2017.05.008","article-title":"AT1 receptor signaling pathways in the cardiovascular system","volume":"125","author":"Kawai","year":"2017","journal-title":"Pharm Res"},{"key":"10.1016\/j.jocmr.2024.101121_bib22","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/hc3401.093149","article-title":"Cardioprotective effects of ramipril and losartan in right ventricular pressure overload in the rabbit","volume":"104","author":"Rouleau","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jocmr.2024.101121_bib23","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocmr.2024.101121_bib24","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jocmr.2024.101121_bib25","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S1071-9164(03)00243-4","article-title":"Losartan reduces hospitalization for heart failure in patients with diabetes and no prior history of heart failure","volume":"9","author":"Devereux","year":"2003","journal-title":"J Card Fail"},{"key":"10.1016\/j.jocmr.2024.101121_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/ndt\/16.suppl_1.85","article-title":"Losartan reduces microalbuminuria in hypertensive microalbuminuric type 2 diabetics","volume":"16","author":"Lozano","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jocmr.2024.101121_bib27","doi-asserted-by":"crossref","first-page":"668","DOI":"10.7326\/0003-4819-140-8-200404200-00028","article-title":"Losartan for microalbuminuria in normotensive type 2 diabetes mellitus","volume":"140","author":"Zandbergen","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jocmr.2024.101121_bib28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","article-title":"Distinguishing features of long COVID identified through immune profiling","volume":"623","author":"Klein","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jocmr.2024.101121_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/10976640009148691","article-title":"Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance","volume":"2","author":"Bellenger","year":"2000","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2024.101121_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9149(02)02381-0","article-title":"Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy","volume":"90","author":"Grothues","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jocmr.2024.101121_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12968-018-0484-5","article-title":"Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I - analytical validation and clinical qualification","volume":"20","author":"Puntmann","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2024.101121_bib32","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jamacardio.2020.3557","article-title":"Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)","volume":"5","author":"Puntmann","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jocmr.2024.101121_bib33","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jocmr.2024.101121_bib34","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Hear J"},{"key":"10.1016\/j.jocmr.2024.101121_bib35","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jacc.2017.12.048","article-title":"2017 Cardiovascular and stroke endpoint definitions for clinical trials","volume":"71","author":"Hicks","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jocmr.2024.101121_bib36","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","article-title":"2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)","volume":"41","author":"Brugada","year":"2020","journal-title":"Eur Hear J"},{"key":"10.1016\/j.jocmr.2024.101121_bib37","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocmr.2024.101121_bib38","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1056\/NEJMoa1716734","article-title":"Magnetic resonance perfusion or fractional flow reserve in coronary disease","volume":"380","author":"Nagel","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocmr.2024.101121_bib39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCRESAHA.116.307974","article-title":"T1 mapping in characterizing myocardial disease","volume":"119","author":"Puntmann","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jocmr.2024.101121_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12968-020-00610-6","article-title":"Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update","volume":"22","author":"Schulz-Menger","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2024.101121_bib41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1532-429X-15-78","article-title":"Standardization of T1 measurements with MOLLI in differentiation between health and disease \u2013 the ConSept study","volume":"15","author":"Rogers","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2024.101121_bib42","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jcmg.2013.10.011","article-title":"CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis","volume":"7","author":"Francone","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2024.101121_bib43","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/eurheartj\/ehaa623","article-title":"COVID-19 is, in the end, an endothelial disease","volume":"41","author":"Libby","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jocmr.2024.101121_bib44","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1161\/CIRCULATIONAHA.120.047349","article-title":"Description and proposed management of the acute COVID-19 cardiovascular syndrome","volume":"141","author":"Hendren","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jocmr.2024.101121_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2020.107300","article-title":"Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations","volume":"50","author":"Halushka","year":"2021","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jocmr.2024.101121_bib46","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1001\/jamacardio.2021.2065","article-title":"Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection","volume":"6","author":"Daniels","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jocmr.2024.101121_bib47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcmg.2015.12.001","article-title":"T1-mapping and outcome in nonischemic cardiomyopathy all-cause mortality and heart failure","volume":"9","author":"Puntmann","year":"2016","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Journal of Cardiovascular Magnetic Resonance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664724011487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664724011487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:54:22Z","timestamp":1793987662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097664724011487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"alternative-id":["S1097664724011487"],"URL":"https:\/\/doi.org\/10.1016\/j.jocmr.2024.101121","relation":{},"ISSN":["1097-6647"],"issn-type":[{"value":"1097-6647","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance Endpoints","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiovascular Magnetic Resonance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocmr.2024.101121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of Society for Cardiovascular Magnetic Resonance.","name":"copyright","label":"Copyright"}],"article-number":"101121"}}